Viking Therapeutics, Inc. (LON:0VQA)
London · Delayed Price · Currency is GBP · Price in USD 31.82
+4.54 (16.64%)
Feb 12, 2026, 5:09 PM GMT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of 2.42 billion as of February 12, 2026. Its market cap has decreased by -19.31% in one year.
Market Cap
2.42B
Enterprise Value
1.90B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
31.82
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from 53.05M to 2.42B, an increase of 4,458.04%. That is a compound annual growth rate of 42.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.59B | -12.46% |
| Dec 31, 2025 | 2.95B | -17.51% |
| Dec 31, 2024 | 3.58B | 145.09% |
| Dec 29, 2023 | 1.46B | 144.27% |
| Dec 30, 2022 | 598.29M | 125.11% |
| Dec 31, 2021 | 265.78M | -11.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |